Drug Shortage Report for PMS-VENLAFAXINE XR
| Report ID | 94073 |
| Drug Identification Number | 02278545 |
| Brand name | PMS-VENLAFAXINE XR |
| Common or Proper name | VENLAFAXINE |
| Company Name | PHARMASCIENCE INC |
| Market Status | DORMANT |
| Active Ingredient(s) | VENLAFAXINE |
| Strength(s) | 37.5MG |
| Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
| Route of administration | ORAL |
| Packaging size | 500 |
| ATC code | N06AX |
| ATC description | ANTIDEPRESSANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2019-07-29 |
| Estimated end date | Unknown |
| Actual end date | 2022-06-27 |
| Shortage status | Resolved |
| Updated date | 2022-07-25 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2022-07-25 | French | Compare |
| v8 | 2022-07-25 | English | Compare |
| v7 | 2021-10-15 | French | Compare |
| v6 | 2021-10-15 | English | Compare |
| v5 | 2021-10-15 | English | Compare |
| v4 | 2021-06-18 | French | Compare |
| v3 | 2021-06-18 | English | Compare |
| v2 | 2019-09-17 | French | Compare |
| v1 | 2019-09-17 | English | Compare |
Showing 1 to 9 of 9